Search

James B Hamby

from Pontiac, MI
Deceased
Get Report
Also known as:
B Hamby James
Related to:
Richard Eric Linder, 51Michelle Lynn Knight, 56Dennis Knight, 56Caron A Aymer, 83Henry G HambyCarolyn K Aymer, 57Loretta K HambyJames S Aymer, 61Diane M Aymer, 63
Connected to:
Aadil Hamby, 45Adrienne S Hamby, 43Alice D Hamby, 88Alicia M Hamby, 53Alisha M Hamby, 31Amie A Hamby, 48Anita A Hamby, 50Aubrey Hamby, 96Bobby Hamby, 86Carolyn W Hamby, 86

James Hamby Phones & Addresses

  • Pontiac, MI
  • 229 Suburban St, Ecorse, MI 48229
  • Westland, MI

Work

Company: Before and again Feb 2010 Position: Shipping supervisor

Education

Degree: High school graduate or higher

Resumes

Resumes

James Hamby Photo 1

James Hamby St. Louis, MO

View page
Work:
Before and Again

Feb 2010 to 2000
Shipping Supervisor
Local Carpenters Union
St. Louis, MO
Jan 2005 to Feb 2010
Floor Technician
F and R Deliveries
St. Louis, MO
Feb 2000 to Jan 2005
Courier
Red Lobster
St. Louis, MO
Jan 2000 to Jan 2005
Bartender

Business Records

Name / Title
Company / Classification
Phones & Addresses
Dr. James R. Hamby
Owner
Hamby, Dr. James R., DDS
Dentists
5708 Uptain Road, Ste. 100, Chattanooga, TN 37411
(423) 877-3411
James Hamby
Principal
James M Hamby Consulting LLC
Business Consulting Services
4390 Chad Ct, Ann Arbor, MI 48103
James David Hamby
MM
Sierra Mechanical, LC

Publications

Us Patents

2-(4-Pyridyl)Amino-6-Dialkoxyphenyl-Pyrido[2,3-D]Pyrimidin-7-Ones

View page
US Patent:
7022711, Apr 4, 2006
Filed:
Jul 20, 2001
Appl. No.:
10/343847
Inventors:
James Marino Hamby - Ann Arbor MI, US
Sylvester Klutchko - Ann Arbor MI, US
James Bernard Kramer - Sylvania OH, US
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
C07D 471/04
A61K 31/519
A61P 35/00
A61P 9/10
A61P 3/10
US Classification:
51426411, 544279
Abstract:
This invention provides antiangiogenic compounds of the Formula (I), which are useful for treating diseases, resulting from uncontrolled cellular proliferation such as cancer, atherosclerosis, rheumatoid arthritis, and psoriasis.

Kinase Inhibitors

View page
US Patent:
7196090, Mar 27, 2007
Filed:
Jul 17, 2003
Appl. No.:
10/621983
Inventors:
Cleo J. Chivikas Connolly - Livonia MI, US
Christopher James Deur - Ann Arbor MI, US
James Marino Hamby - Ann Arbor MI, US
Denton Wade Hoyer - Dexter MI, US
Chris Limberakis - Saline MI, US
Jessica Elizabeth Reed - Ann Arbor MI, US
Mel Conrad Schroeder - Dexter MI, US
Clarke Taylor - Ann Arbor MI, US
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A01N 43/54
A61K 31/505
C07D 487/00
US Classification:
514258, 544256
Abstract:
This invention provides phenyl-substituted pyrimidopyrimidines, dihydropyrimido-pyrimidines, pyridopyrimidines, naphthyridines, and pyridopyrazines of the general formula:.

Bicyclic Pyrimidines And Bicyclic 3,4-Dihydropyprimidines As Inhibitors Of Cellular Proliferation

View page
US Patent:
7501425, Mar 10, 2009
Filed:
May 10, 1999
Appl. No.:
09/623737
Inventors:
Ellen Myra Dobrusin - Ann Arbor MI, US
James Marino Hamby - Ann Arbor MI, US
James Bernard Kramer - Sylvania OH, US
Mel Conrad Schroeder - Dexter MI, US
Howard Daniel Hollis Showalter - Ann Arbor MI, US
Peter Toogood - Ann Arbor MI, US
Susanne A. Trumpp-Kallmeyer - Moeindal, DE
Assignee:
Warner Lambert Company - New York NY
International Classification:
A61K 31/519
C07D 471/04
US Classification:
5142621, 544256
Abstract:
This invention provides substituted pyrimido-pyrimidines that are useful for treating cell proliferative disorders, such as cancer and restenosis, as well as angiogenesis and atherosclerosis. The invention compounds have Formula I:The invention also provides pharmaceutical formulations comprising a compound of Formula I together with a pharmaceutically acceptable carrier, diluent, or excipient therefor, and a method for treating angiogenesis using said compounds.

Bicyclic Pyrimidines And Bicyclic 3,4-Dihydropyrimidines As Inhibitors Of Cellular Proliferation

View page
US Patent:
20040044012, Mar 4, 2004
Filed:
Aug 11, 2003
Appl. No.:
10/638848
Inventors:
Ellen Dobrusin - Ann Arbor MI, US
James Hamby - Ann Arbor MI, US
James Kramer - Sylvania OH, US
Mel Schroeder - Dexter MI, US
Howard Showalter - Ann Arbor MI, US
Peter Toogood - Ann Arbor MI, US
Susanne Trumpp-Kallmeyer - Haigerloch, DE
International Classification:
A61K031/519
US Classification:
514/262100, 544/255000
Abstract:
This invention provides bicyclic heterocycles that are useful for treating cell proliferative disorders, such as cancer and restenosis, as well as angiogenesis and atherosclerosis. We have now discovered a group of bicyclic compounds that are potent inhibitors of cyclin-dependent kinases (cdks), growth factor-mediated kinases, and non-receptor kinases. The compounds are readily synthesized and can be administered by a variety of routes, including orally, and have sufficient bioavailability for clinical use. This invention provides compounds of Formula I: where Z is N or CH; G is N or CH; W is NH, S, SO, or SO, Rincludes phenyl and substituted phenyl, Rincludes alkyl and cycloalkyl, Rincludes alkyl and hydrogen, Rand Rinclude hydrogen and alkyl, and the pharmaceutically acceptable salts thereof. This invention also provides pharmaceutical formulations comprising a compound of Formula I together with a pharmaceutically acceptable carrier, diluent, or excipient therefor.

[B]-Fused Bicyclic Proline Derivatives And Their Use For Treating Arthritic Conditions

View page
US Patent:
20050143427, Jun 30, 2005
Filed:
Apr 12, 2004
Appl. No.:
10/822389
Inventors:
Nicole Barvian - Ann Arbor MI, US
Cleo Connolly - Livonia MI, US
Peter Guzzo - Niskayuna NY, US
James Hamby - Ann Arbor MI, US
James Hicks - Chelsea MI, US
Matthew Johnson - Guilderland NY, US
Van-Duc Le - Selkirk NY, US
Lorna Mitchell - Dexter MI, US
William Roark - Ann Arbor MI, US
International Classification:
A61K031/433
A61K031/4245
C07D417/02
C07D413/02
US Classification:
514361000, 514362000, 514364000, 514381000, 548253000, 548129000, 548135000
Abstract:
This invention relates to a compound which is [b]-fused bicyclic proline derivative, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising the compound or the salt thereof, and methods of treating diseases, including, but not limited to, methods of preventing or inhibiting joint cartilage damage and preventing or treating diseases characterized by joint cartilage damage, joint inflammation, or joint pain. The [b]-fused bicyclic proline derivatives are compounds of Formula I as described above. Diseases characterized by joint cartilage damage or joint pain include, for example, osteoarthritis and rheumatoid arthritis. Rheumatoid arthritis is also characterized by joint inflammation. This invention also relates to methods of synthesizing and preparing the [b]-fused bicyclic proline derivatives, or a pharmaceutically acceptable salt thereof.

Pyrido [2,3-D]Pyrimidines For Inhibiting Protein Tyrosine Kinase Mediated Cellular Proliferation

View page
US Patent:
56209819, Apr 15, 1997
Filed:
May 3, 1995
Appl. No.:
8/433294
Inventors:
Clifton J. Blankley - Ann Arbor MI
Diane H. Boschelli - Plymouth MI
Annette M. Doherty - Ann Arbor MI
James M. Hamby - Ann Arbor MI
Sylvester Klutchko - Ann Arbor MI
Robert L. Panek - Canton MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 31505
C07D48702
US Classification:
514258
Abstract:
6-Aryl pyrido[2,3-d]pyrimidine 7-imines, 7-ones, and 7-thiones are inhibitors of protein tyrosine kinases, and are thus useful in treating cellular proliferation mediated thereby. The compounds are especially useful in treating cancer, atherosclerosis, restenosis, and psoriasis.

6-Aryl Pyrido?2,3-D! Pyrimidines And Naphthyridines For Inhibiting Protein Tyrosine Kinase Mediated Cellular Proliferation

View page
US Patent:
57339139, Mar 31, 1998
Filed:
Nov 6, 1995
Appl. No.:
8/539410
Inventors:
Clifton John Blankley - Ann Arbor MI
Annette Marian Doherty - Ann Arbor MI
James Marino Hamby - Ann Arbor MI
Robert Lee Panek - Canton MI
Mel Conrad Schroeder - Dexter MI
Howard Daniel Hollis Showalter - Ann Arbor MI
Cleo Connolly - Livonia MI
International Classification:
C07D47104
A61K 31505
US Classification:
514258
Abstract:
6-Aryl pyrido�2,3-d!pyrimidines and naphthyridines are inhibitors of protein tyrosine kinase, and are thus useful in treating cellular proliferation mediated thereby. The compounds are especially useful in treating atherosclerosis, restenosis, psoriasis, as well as bacterial infections.

Substituted Imidazolinyl-Imidazolines As Antagonists Of Sh-2 Binding And Therapeutic Uses Thereof

View page
US Patent:
57212660, Feb 24, 1998
Filed:
Sep 26, 1994
Appl. No.:
8/312253
Inventors:
Stuart James Decker - Ann Arbor MI
David William Fry - Ypsilanti MI
James Marino Hamby - Ann Arbor MI
Alan Robert Saltiel - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A01N 4350
US Classification:
514398
Abstract:
Methods of treating proliferative diseases or viral, inflammatory, allergic and cardiovascular diseases, and restenosis are disclosed. The present invention demonstrates the use of N,N'-piperazinylbis-�2-amino-1-imidazolin-2-yl)-2-imidazolines!, 2-amino-1-(2-imidazolin-2-yl)-2-imidazolines, and N,N'-alkylene-bis�2-amino-1-(2-imidazolin-2-yl)-2-imidazolines!, their derivatives, and salts thereof, to antagonize the association of a protein tyrosine kinase with a substrate regulatory protein. The present invention also demonstrates the use of pharmaceutical compositions employing N,N'-piperazinylbis�2-amino-1-imidazolin-2-yl)-2-imidazolines!, 2-amino-1-(2-imidazolin-2-yl)-2-imidazolines, and N,N'-alkylenebis-�2-amino-1-(2-imidazolin-2-yl)-2-imidazolines!, their derivatives, and salts thereof, to antagonize the association of a protein tyrosine kinase with substrate regulatory protein. The present invention also relates to novel N,N'-piperazinylbis�2-amino-1-imidazolin-2-yl)-2-imidazolines!.
Control profile
James B Hamby from Pontiac, MIDeceased Get Report